Cure My Disease

Don't miss your cure!

 Log in / Sign up

BioNTech tests new cancer drug in first human trial

NCT ID NCT06750185

Recruiting now Disease control Sponsor: BioNTech SE Source: ClinicalTrials.gov ↗

Summary

This is the first human study of a new cancer drug called BNT317, developed by BioNTech. It will test the safety and find the right dose for patients with advanced solid tumors who have run out of standard treatment options. The study will enroll 39 participants and follow them for up to two years to see how their bodies handle the drug and if it shows any signs of fighting their cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cancer Research SA

    RECRUITING

    Adelaide, 5000, Australia

  • Carolina BioOncology Institute, LLC

    RECRUITING

    Huntersville, North Carolina, 28078, United States

  • MUSC Hollings Cancer Center

    RECRUITING

    Charleston, South Carolina, 29425, United States

  • Mary Crowley Cancer Research

    RECRUITING

    Dallas, Texas, 75230, United States

  • Monash Medical Centre Clayton

    RECRUITING

    Clayton, 3168, Australia

  • Norton Cancer Institute PARENT

    RECRUITING

    Louisville, Kentucky, 40202, United States

  • Rhode Island Hospital

    RECRUITING

    East Providence, Rhode Island, 02903, United States

  • START Midwest

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

  • Scientia Clinical Research

    RECRUITING

    Randwick, 2031, Australia

  • South Texas Accelerated Research Therapeutics (START), LLC

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Tasman Oncology Research Ltd

    RECRUITING

    Southport, Queensland, 4215, Australia

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMOR